Cargando…
Senescence and senolytics in cardiovascular disease: Promise and potential pitfalls
Ageing is the biggest risk factor for impaired cardiovascular health, with cardiovascular disease being the cause of death in 40 % of individuals over 65 years old. Ageing is associated with an increased prevalence of atherosclerosis, coronary artery stenosis and subsequent myocardial infarction, th...
Autores principales: | Owens, W Andrew, Walaszczyk, Anna, Spyridopoulos, Ioakim, Dookun, Emily, Richardson, Gavin D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Science Ireland
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8387860/ https://www.ncbi.nlm.nih.gov/pubmed/34237321 http://dx.doi.org/10.1016/j.mad.2021.111540 |
Ejemplares similares
-
Therapeutic Potential of Senolytics in Cardiovascular Disease
por: Dookun, Emily, et al.
Publicado: (2020) -
Pharmacological clearance of senescent cells improves survival and recovery in aged mice following acute myocardial infarction
por: Walaszczyk, Anna, et al.
Publicado: (2019) -
Senescent cardiomyocytes contribute to cardiac dysfunction following myocardial infarction
por: Redgrave, Rachael, et al.
Publicado: (2023) -
Senescent cardiomyocytes contribute to cardiac dysfunction following myocardial infarction
por: Redgrave, Rachael E., et al.
Publicado: (2023) -
Author Correction: Senescent cardiomyocytes contribute to cardiac dysfunction following myocardial infarction
por: Redgrave, Rachael E., et al.
Publicado: (2023)